EW
Edwards Lifesciences
Health Care
Health Care Equipment
Irvine, California
Balance Sheet 36 Accounts • 5 Years
| Account | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets - CashAndCashEquivalents | $3.0B | $1.1B | $769.0M | $862.8M | $1.2B |
| Assets - ShortTermInvestments | $930.7M | $500.5M | $446.3M | $604.0M | $219.4M |
| Assets - AccountsReceivable | $609.1M | $771.5M | $643.0M | $582.2M | $514.6M |
| Assets - Inventories | $1.1B | $903.5M | $875.5M | $726.7M | $802.3M |
| Assets - PrepaidExpensesAndOtherCurrentAssets | $347.6M | $224.9M | $195.9M | $237.1M | $208.2M |
| Assets - TotalCurrentAssets | $6.3B | $4.0B | $3.1B | $3.2B | $3.1B |
| Assets - Property,PlantAndEquipment | $1.7B | $1.6B | $1.6B | $1.5B | $1.4B |
| Assets - Goodwill | $1.8B | $1.1B | $1.1B | $1.2B | $1.2B |
| Assets - IntangibleAssets(net,ExcludingGoodwill) | $1.2B | $399.4M | $285.2M | $323.6M | $331.4M |
| Assets - OperatingLeaseAssets | $98.2M | $84.4M | $92.3M | $92.1M | $94.2M |
| Assets - DeferredTaxAssets | $992.1M | $749.4M | $484.0M | $246.7M | $230.9M |
| Assets - LongTermInvestments | $307.9M | $583.9M | $1.2B | $1.8B | $801.6M |
| Assets - OtherNoncurrentAssets | $721.6M | $463.2M | $299.1M | $110.8M | $119.6M |
| Assets - TotalNoncurrentAssets | $1.8B | $1.7B | $1.6B | $1.7B | $1.6B |
| Assets - TotalAssets | $13.1B | $9.4B | $8.3B | $8.5B | $7.2B |
| Liabilities - AccountsPayable | $197.4M | $186.6M | $201.9M | $204.5M | $196.5M |
| Liabilities - AccruedLiabilities | $96.4M | $79.7M | $72.2M | $87.6M | $88.2M |
| Liabilities - OperatingLeaseLiabilitiesCurrent | $23.4M | $22.9M | $25.5M | $25.5M | $27.2M |
| Liabilities - OtherCurrentLiabilities | $8.3M | $15.2M | $20.7M | $3.9M | $39.3M |
| Liabilities - TotalCurrentLiabilities | $1.5B | $1.2B | $1.0B | $1.0B | $893.9M |
| Liabilities - LongTermDebt | $597.7M | $597.0M | $596.3M | $595.7M | $595.0M |
| Liabilities - OperatingLeaseLiabilitiesNoncurrent | $78.9M | $65.2M | $69.5M | $69.1M | $72.7M |
| Liabilities - DeferredTaxLiabilitiesNoncurrent | $331.2M | $135.0M | $128.2M | $181.0M | $169.0M |
| Liabilities - ContingentConsiderationLiabilityNoncurrent | $14.5M | $0 | $26.2M | $62.0M | $186.1M |
| Liabilities - OtherNoncurrentLiabilities | $357.5M | $251.3M | $217.5M | $267.3M | $252.4M |
| Liabilities - TotalLiabilities | $3.0B | $2.6B | $2.5B | $2.7B | $2.7B |
| Equity - PreferredStock | $0 | $0 | $0 | $0 | $0 |
| Equity - CommonStock | $654.8M | $650.5M | $646.3M | $642.0M | $636.4M |
| Equity - AdditionalPaidInCapital | $2.6B | $2.3B | $2.0B | $1.7B | $1.4B |
| Equity - RetainedEarnings(deficit) | $13.2B | $9.0B | $7.6B | $6.1B | $4.6B |
| Equity - AccumulatedOtherComprehensiveIncome(loss) | $-244.5M | $-242.8M | $-254.9M | $-157.7M | $-161.1M |
| Equity - TotalStockholdersEquity | $10.0B | $6.7B | $5.8B | $5.8B | $4.6B |
| Equity - TotalLiabilitiesAndStockholdersEquity | $13.1B | $9.4B | $8.3B | $8.5B | $7.2B |
| Equity - TotalLiabilitiesandEquity | $13.0B | $9.3B | $8.3B | $8.5B | $7.2B |
| Validation - L+E Components Sum Difference | $0 | $0 | $0 | $0 | $0 |